The Paris-based venture capital firm, Kurma Partners, manages several funds, including the Kurma Biofund I, II, and Kurma Diagnostics fund, and has become a major player in the financing of therapeutic and medical innovations in Europe. With €470 million under management, Kurma Partners invests from pre-seed to growth capital and has established strategic partnerships with prestigious European research and medical institutions. Kurma Biofund focuses on therapeutic innovation, while Kurma Diagnostics is dedicated to diagnostic and digital health innovation. Founded in 2009, Kurma Partners has become a key European venture capital group in the healthcare and biotechnology sectors.